These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7609145)

  • 1. Tamoxifen enhances the chemosensitivity of bladder carcinoma cells.
    Pu YS; Hsieh TS; Tsai TC; Cheng AL; Hsieh CY; Su IJ; Lai MK
    J Urol; 1995 Aug; 154(2 Pt 1):601-5. PubMed ID: 7609145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
    Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC
    Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Canavanine modulates cellular growth, chemosensitivity and P-glycoprotein substrate accumulation in cultured human tumor cell lines.
    Worthen DR; Chien L; Tsuboi CP; Mu XY; Bartik MM; Crooks PA
    Cancer Lett; 1998 Oct; 132(1-2):229-39. PubMed ID: 10397478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response.
    Pu YS; Tsai TC; Cheng AL; Tsai CY; Tseng NF; Su IJ; Hsieh CY; Lai MK
    J Urol; 1996 Jul; 156(1):271-5. PubMed ID: 8648821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
    Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
    Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
    Sharp SY; Rowlands MG; Jarman M; Kelland LR
    Br J Cancer; 1994 Sep; 70(3):409-14. PubMed ID: 8080723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multiple drug resistance in human bladder cancer cell lines.
    Shinohara N; Liebert M; Wedemeyer G; Chang JH; Grossman HB
    J Urol; 1993 Aug; 150(2 Pt 1):505-9. PubMed ID: 8100862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines.
    Page RL; Hughes CS; Huyan S; Sagris J; Trogdon M
    Anticancer Res; 2000; 20(5B):3533-8. PubMed ID: 11131658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
    Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
    Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM.
    Kimiya K; Naito S; Soejima T; Sakamoto N; Kotoh S; Kumazawa J; Tsuruo T
    J Urol; 1992 Aug; 148(2 Pt 1):441-5. PubMed ID: 1353119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a multidrug-resistant human bladder carcinoma cell line RT112/D21.
    Seemann O; Muscheck M; Siegsmund M; Pilch H; Nebe CT; Rassweiler J; Alken P
    Urol Res; 1995; 22(6):353-60. PubMed ID: 7740654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma.
    Yanagisawa T; Newman A; Coley H; Renshaw J; Pinkerton CR; Pritchard-Jones K
    Br J Cancer; 1999 Jun; 80(8):1190-6. PubMed ID: 10376971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil (VER) Enhances the Cytotoxic Effects of Docetaxel and Vinblastine Combined Therapy Against Non-Small Cell Lung Cancer Cell Lines.
    Jaferian S; Soleymaninejad M; Daraee H
    Drug Res (Stuttg); 2018 Mar; 68(3):146-152. PubMed ID: 29132176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
    Haberl I; Swatonek H; Schaufler K; Ulsperger E; Wenzl E; Theyer G; Hamilton G; Thalhammer T
    Int J Oncol; 1998 May; 12(5):1137-42. PubMed ID: 9538140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
    Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines.
    Zalcberg JR; Hu XF; Ching M; Wakeling A; Wall DM; Marschner IC; de Luise M
    Cancer Chemother Pharmacol; 1993; 33(2):123-9. PubMed ID: 7903222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.